Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Edesa Biotech, Inc. | tv506256_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Edesa Biotech, Inc. | tv506256_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Edesa Biotech, Inc. | tv506256_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Edesa Biotech, Inc. | tv506256_ex31-1.htm |
| EX-3.6 - EXHIBIT 3.6 - Edesa Biotech, Inc. | tv506256_ex3-6.htm |
| 10-K - FORM 10-K - Edesa Biotech, Inc. | tv506256_10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-217480) of Stellar Biotechnologies, Inc. of our report dated November 30, 2018, relating to the consolidated financial statements of Stellar Biotechnologies, Inc., which report appears in this Annual Report on Form 10-K for the year ended September 30, 2018.
/s/ Moss Adams LLP |
|
| Los Angeles, California | |
| November 30, 2018 |